• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

    39.82 +1.11 (+2.87%)
    Streaming Delayed Price Updated: 9:42 AM EDT, Jul 7, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 240,849
    Open 39.09
    Bid (Size) 39.68 (100)
    Ask (Size) 39.96 (1,000)
    Prev. Close 38.71
    Today's Range 38.68 - 39.99
    52wk Range 22.96 - 43.15
    Shares Outstanding 99,581,693
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗
    One company leads in gene-editing approvals, while the other targets surging demand in metabolic treatments. Here’s how their financials and risk profiles compare. 
    Via The Motley Fool
    News headline image
    Could This Healthcare Stock Help You Build a Real Fortune Over the Next 20 Years? ↗
    The weight-loss market is crowded, but this company's lead drug candidate has several key advantages. 
    Via The Motley Fool

    Performance

    YTD
    +12.4%
    +12.4%
    1 Month
    +36.2%
    +36.2%
    3 Month
    +17.4%
    +17.4%
    6 Month
    +23.9%
    +23.9%
    1 Year
    +44.7%
    +44.7%

    More News

    Read More
    News headline image
    How Much Could $1,000 Invested in Viking Therapeutics Be Worth by 2030? ↗
    Via The Motley Fool
    News headline image
    Is Viking Therapeutics Stock Going to $50? Here's What the Bulls and Bears Are Saying ↗
    Via The Motley Fool
    News headline image
    Here's Why Viking Therapeutics Stock Surged Higher in June ↗
    Via The Motley Fool
    News headline image
    Is Viking Therapeutics Stock Going to $100? ↗
    Via The Motley Fool
    News headline image
    Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could ↗
    Via The Motley Fool
    News headline image
    Dyne Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗
    Via The Motley Fool
    News headline image
    Eli Lilly vs Viking Therapeutics: Which GLP-1 Stock Is the Better Buy? ↗
    Via The Motley Fool
    News headline image
    Is Viking Therapeutics Stock a No-Brainer Buy Below $35? ↗
    Via The Motley Fool
    News headline image
    Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk ↗
    Via The Motley Fool
    News headline image
    Set It and Forget It: 2 Consumer Stocks to Hold for the Next 20 Years ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Is Viking Therapeutics Stock Going to $100? ↗
    Via The Motley Fool
    News headline image
    Why 1 Wall Street Analyst Thinks Viking Therapeutics Stock Could Soar 188% ↗
    Via The Motley Fool
    News headline image
    1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't ↗
    Via The Motley Fool
    News headline image
    Bull vs. Bear: The Quick Take on Viking Therapeutics Stock ↗
    Via The Motley Fool
    News headline image
    Viking Therapeutics' Q3 Catalyst That Could Turn Eli Lilly's and Novo Nordisk's Daily Weight Loss Pill Strategy Upside Down ↗
    Via The Motley Fool
    News headline image
    The Smartest Growth Stocks to Buy With $2,000 Right Now ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Prediction: These 2 Obesity Drug Stocks Could Double in 2026 ↗
    Via The Motley Fool
    News headline image
    Don't Buy Viking Therapeutics Stock Until You Read This ↗
    Via The Motley Fool
    News headline image
    Eli Lilly Just Made a Game-Changing Move in the Billion-Dollar Weight Loss Drug Space. Here's What You Need to Know. ↗
    Via The Motley Fool
    News headline image
    Is Viking Therapeutics a Top Takeover Target? ↗
    Via The Motley Fool
    News headline image
    2 Stocks That Could Realistically Double by 2030 ↗
    Via The Motley Fool
    News headline image
    Could Viking Therapeutics Be the Next Eli Lilly? ↗
    Via The Motley Fool
    News headline image
    Best Weight Loss Drug Stocks to Buy in 2026 ↗
    Via The Motley Fool
    Topics Intellectual Property

    Frequently Asked Questions

    Is Viking Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
    Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
    The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
    What is the current price of Viking Therapeutics, Inc. - Common Stock?
    The current price of Viking Therapeutics, Inc. - Common Stock is 39.82
    When was Viking Therapeutics, Inc. - Common Stock last traded?
    The last trade of Viking Therapeutics, Inc. - Common Stock was at 07/07/26 09:42 AM ET
    What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
    The market capitalization of Viking Therapeutics, Inc. - Common Stock is 3.97B
    How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
    Viking Therapeutics, Inc. - Common Stock has 4B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.